Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes from an Ongoing Phase 3, Multicenter, Randomized, Active- and Placebo-Controlled Study (CIMPACT)

Main Article Content

Vincent Piguet
Andrew Blauvelt
Daniel Burge
Luke Peterson
Janice Drew
Robert Rolleri
Jolanta Weglowska


psoriasis, certolizumab, randomized trial, multicenter


Abstract Not Available


Disclosure: Study supported by Dermira.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 > >>